MAP Pharmaceuticals Financial Market Data
| Last Close 25-Sep-2008 |
$9.97 |
Price/ Sales Ratio |
-- |
| 52-Week High |
$20.00 |
Price/ Book Ratio |
2.24 |
| 52-Week Low |
$6.68 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
-- |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$203.4 |
Return on Assets |
(65.5%) |
| Shares Outstanding (mil.) |
20.4 |
Return on Equity |
(349.4%) |
| Dividend Rate |
-- |
Current Ratio |
7.54 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
0.12 |
| # of Institutional Holders |
42 |
% Owned by Institutions |
94.0% |
| Latest Short Interest Ratio |
14.16 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
0.0% |
0.0% |
0.0% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |

This data is provided as per license from EDGAR Online